JA
SAGE

JOYN Advisors’s Sage Therapeutics SAGE Stock Holding History

JOYN Advisors’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-289
Closed -$28K – 1141
2018
Q4 		$28K Sell
289
-71
-20% -$8.13K 0.01% 536
2018
Q3 		$51K Sell
360
-158
-31% -$24.4K 0.01% 388
2018
Q2 		$81K Sell
518
-277
-35% -$43.5K 0.02% 268
2018
Q1 		$128K Buy
+795
New +$135K 0.03% 197

Other funds holding SAGE

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

JOYN Advisors's SAGE Position: Q1 2019 in Review

JOYN Advisors sold out of Sage Therapeutics (SAGE) in Q1 2019, closing a stake of 289 shares — an estimated $28K sold.

JOYN Advisors first reported a position in SAGE in Q1 2018 and held it in 4 quarters. The position peaked at $128K in Q1 2018. 268 funds tracked by Wall St. Rank hold SAGE as of Q1 2019.

  • JOYN Advisors reported no remaining Sage Therapeutics position as of Q1 2019 after selling out during the quarter.
  • JOYN Advisors sold 289 Sage Therapeutics shares in Q1 2019, an estimated $28K.
  • JOYN Advisors first reported a position in Sage Therapeutics in Q1 2018 and held it in 4 quarters.
  • JOYN Advisors's Sage Therapeutics position peaked at $128K in Q1 2018.
  • 268 funds tracked by Wall St. Rank held Sage Therapeutics as of Q1 2019.

Based on JOYN Advisors's 13F filing for Q1 2019, filed 9 May 2019.